A new clinical trial is underway to evaluate the safety and effectiveness of onabotulinumtoxinA, better known as BOTOX, for treating Masseter Muscle Prominence (MMP) — a condition where the jaw muscles used for chewing appear more pronounced than some individuals would like. This development highlights the ongoing exploration of botulinum toxin’s versatility beyond its well-known cosmetic and therapeutic uses for wrinkles and muscle spasms.
The study, registered on ClinicalTrials.gov, will enroll approximately 200 adult participants across roughly 20 sites in the United States. Researchers are using a carefully designed two-period approach: in the first phase, participants will be randomly assigned to receive either BOTOX or a placebo injection into the masseter muscles on both sides of the face. This rigorous, placebo-controlled design helps ensure that any observed benefits can be confidently attributed to the treatment itself rather than other factors.
Notably, the trial also includes an optional second phase where eligible participants can receive an open-label BOTOX retreatment, allowing researchers to gather valuable data on repeated dosing and longer-term outcomes. Participants will be closely monitored through regular visits, medical assessments, and questionnaires over a follow-up period of up to six months, reflecting a thorough commitment to participant safety and data quality.
If successful, this research could pave the way for an additional, minimally invasive option for individuals seeking to address masseter prominence without surgery. Botulinum toxin injections are already widely used and understood for their muscle-relaxing properties, and expanding their studied applications to include this specific cosmetic and functional concern reflects the growing versatility of peptide-based and neurotoxin therapies in modern aesthetic medicine.
Clinical trials like this one are an essential part of bringing safe, well-studied treatments to patients. By rigorously testing both efficacy and safety in a controlled setting, researchers aim to provide clearer answers for individuals who may benefit from this type of treatment in the future. As with all clinical research, results will need to be published and peer-reviewed before any conclusions can be drawn about the treatment’s broader availability or effectiveness.
This article is for informational purposes only and does not constitute medical advice. Please consult a qualified healthcare provider for guidance on any treatment options.
Curated by True North Labs. More at truenorthlabs.co. Informational only – not medical advice.
Leave a Reply